Clinical trial
Randomized Evaluation of D-dimer Guiding Duration of Oral Anticoagulation Therapy in Patients With Bioprosthetic Heart Valves
NCT03885180 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Evaluation of D-dimer Guiding Duration of Oral Anticoagulation Therapy in Patients With Bioprosthetic Heart Valves
- Lead sponsor
- Wuhan Asia Heart Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 20, 2019
- Completion date
- March 30, 2021
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulants; increased, valve heart disease